7 Matching Annotations
  1. Jan 2022
  2. Nov 2021
  3. Aug 2020
  4. Nov 2017
    1. Via email, the primary investigator of COURAGE, Dr William Boden (Boston University, MA), highlighted that investigators found no subset of patients that did better with PCI vs OMT. Not those with multivessel disease and EF<50%, not those with LAD disease, and not those with nuclear studies showing moderate-severe ischemia.[7–9]